Stopped Cold: What Happens When a Pain Clinic Ends Opioid Treatment With No Taper

There is a word for what is supposed to happen when a doctor takes a patient off opioids after years. The word is taper. You come down slowly, over months, with someone watching. That is the whole of it. It is not complicated and it is not controversial.

I did not get one.

Six years on the same regimen. Stable. Working. Running a company, badly some days and well on others, the way anyone does. There was no crisis to manage and no problem to solve. Then the clinic changed my medication twice, and then it stopped it.

The first change was the one I did not understand at the time. They moved me to a higher-strength tablet. Fewer pills in the bottle, more milligrams in each one. I was told, more or less directly, that the DEA had taken an interest in the practice. The number that fell was the number of pills dispensed. The number that rose was the amount of opioid in me.

Say it the plain way. My total opiate went up. My pill count went down.

Sit with that, because it took me a while. The count a regulator watches went down. The amount of opioid in a human being went up. One of those is a metric. The other is a person.

And the second one is the one that builds dependence. Not the number of tablets in the bottle — the total load. So the change did not just fail to help me. It made me more physically dependent than my condition actually called for, and it did that in the service of a number on somebody's report.

The second change replaced one of my medications with morphine at a lower equivalent. Same stated reason: fewer pills.

Then it stopped entirely.

Not reduced. Not stepped down. Stopped.

I have since learned what the government says about this, and it is not ambiguous. In April 2019 the FDA issued a drug safety communication about serious harm in patients who are physically dependent on opioid medicines when those medicines are suddenly discontinued or rapidly decreased. The harms it listed were serious withdrawal, uncontrolled pain, psychological distress, and suicide.

The FDA did not stop at a warning. It required the prescribing information itself to be changed, so that instructions on gradual, individualized tapering appear on the label of the drug.

On the label.

I keep returning to that, because of what it means. A pain physician cannot say he had not come across the research. The warning is printed on the product he writes for. It is the most ordinary document in his working life.

CDC guidance from 2022 puts the pace for a long-term patient at something like ten percent a month, with monitoring. Ten percent a month, for someone who had been on it six years, is close to a year of careful work.

I got none of it. Not one step.

I asked, in writing. I have the date. Nothing came back.

What I want to say to anyone reading this who is in the same position, and I think there are more of us than anybody counts: the taper is not a favor. It is not something you talk a doctor into on a good day. It is the standard of care, it is on the label, and a prescription for it takes about ninety seconds to write. A referral to an addiction medicine clinic takes ten minutes and carries no prescribing risk at all.

Two doors. Both easy. Both open.

Neither one used.